Evidence-Based Medicine Guidelines
Chemotherapy and immunotherapy of malignant mesothelioma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy and Immunotherapy of Malignant Mesothelioma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma.
Chemotherapy and immunotherapy of malignant mesothelioma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma. Accessed December 30, 2024.
Chemotherapy and immunotherapy of malignant mesothelioma. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma
Chemotherapy and Immunotherapy of Malignant Mesothelioma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy and immunotherapy of malignant mesothelioma
ID - 455327
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
